211 related articles for article (PubMed ID: 17526382)
1. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
Labinson P; Taxel P
Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
[No Abstract] [Full Text] [Related]
2. Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
MacGowan JR; Pringle J; Morris VH; Stamp TC
Skeletal Radiol; 2000 May; 29(5):279-82. PubMed ID: 10883448
[TBL] [Abstract][Full Text] [Related]
3. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
[TBL] [Abstract][Full Text] [Related]
4. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
[No Abstract] [Full Text] [Related]
5. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
Eyres KS; Marshall P; McCloskey E; Douglas DL; Kanis JA
Drug Saf; 1992; 7(2):162-5. PubMed ID: 1605902
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
[TBL] [Abstract][Full Text] [Related]
7. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
Abelson A
Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
[TBL] [Abstract][Full Text] [Related]
8. Disodium etidronate (EHDP).
Evans RA
Med J Aust; 1984 Feb; 140(3):182-3. PubMed ID: 6420653
[No Abstract] [Full Text] [Related]
9. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
10. [Optimizing therapy in Paget disease].
Füessl HS
MMW Fortschr Med; 2005 Dec; 147(51-52):32. PubMed ID: 16402704
[No Abstract] [Full Text] [Related]
11. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
Pirih FQ; Zablotsky M; Cordell K; McCauley LK
J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
[TBL] [Abstract][Full Text] [Related]
12. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
[No Abstract] [Full Text] [Related]
13. Paget's disease of bone.
Schnur W
Med J Aust; 1983 Nov; 2(10):479. PubMed ID: 6415375
[No Abstract] [Full Text] [Related]
14. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Krane SM
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
[No Abstract] [Full Text] [Related]
15. [Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
Alexandre C; Trillet M; Meunier P; Fischer C
Rev Neurol (Paris); 1979 Oct; 135(8-9):625-32. PubMed ID: 161056
[TBL] [Abstract][Full Text] [Related]
16. Osteolytic Paget's disease of bone under unduly etidronate therapy.
Wendling D; Guidet M
Clin Rheumatol; 1988 Dec; 7(4):543-5. PubMed ID: 3149926
[No Abstract] [Full Text] [Related]
17. Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.
Evans RA; Dunstan CR; Hills E; Wong SY
Aust N Z J Med; 1983 Jun; 13(3):277-9. PubMed ID: 6416243
[TBL] [Abstract][Full Text] [Related]
18. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
[No Abstract] [Full Text] [Related]
19. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
Gibbs CJ; Aaron JE; Peacock M
Br Med J (Clin Res Ed); 1986 May; 292(6530):1227-9. PubMed ID: 3085789
[TBL] [Abstract][Full Text] [Related]
20. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
Boyce BF; Smith L; Fogelman I; Johnston E; Ralston S; Boyle IT
Lancet; 1984 Apr; 1(8381):821-4. PubMed ID: 6143140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
